Tim Costello

Title: Tim Costello: Innovator in Opioid Receptor Modulator Formulations

Introduction

Tim Costello is a prominent inventor based in Rockville, MD, known for his significant contributions to the field of medicinal formulations. With an impressive portfolio of 9 patents, Costello has made notable advances in developing abuse-deterrent opioid receptor modulators, contributing to safer therapeutic options in pain management.

Latest Patents

Among his latest innovations, Costello has developed formulations that revolutionize the administration of opioid receptor modulators. His recent patents include innovative abuse-deterrent solid dosage formulations containing specific chemical compounds, such as 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid. These formulations not only enhance the therapeutic efficacy but also prioritize user safety by deterring misuse.

Career Highlights

Tim Costello is affiliated with Allergan Holdings Unlimited Company, where he contributes his expertise in pharmaceutical innovations. His work has been instrumental in developing solutions that address the rising concerns surrounding opioid misuse, showcasing his commitment to public health and safety.

Collaborations

Throughout his career, Costello has collaborated with esteemed colleagues, including Jens Jozef Ceulemans and Eugeen Maria Jozef Jans. Together, they have worked on pioneering advancements that enhance the effectiveness and safety of opioid formulations, underscoring the importance of teamwork in the field of pharmaceutical research.

Conclusion

In summary, Tim Costello is a dedicated inventor whose work in the development of opioid receptor modulator formulations is paving the way for safer medical practices. His significant contributions to patent registrations in this field reveal his commitment to innovation and improvement in therapeutic solutions, making a lasting impact on the industry.